ReviewMolecular neurobiology2026
Mechanistic Integration of Beta-Alanine-Carnosine Buffering and Glutamine Metabolism in Exercise-Induced Muscle-Brain Crosstalk: Implications for Aging, Neurodegeneration, and Cognitive Decline.
Review in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aging is marked by a gradual deterioration in muscular performance, cognitive abilities, and metabolic flexibility, phenomena that are intricately linked through the muscle-brain axis. Recent research indicates that particular amino acids, notably beta-alanine (BA) and glutamine, may not function in isolation but instead converge mechanistically to modulate this axis through synergistic influences on intracellular pH regulation, nitrogen metabolism, and redox equilibrium. BA, through its involvement in the biosynthesis of carnosine, augments intracellular buffering capacity and maintains pH stability during metabolic stress scenarios such as exercise and age-related mitochondrial dysfunction. This buffering capability holds particular significance for pH-sensitive enzymes implicated in glutamine metabolism, such as glutamine synthetase and glutaminase, thereby potentially safeguarding glutamine turnover and nitrogen flux in acidic environments. Simultaneously, glutamine operates as a pivotal metabolic substrate that connects skeletal muscle and the brain by facilitating energy homeostasis, immune modulation, antioxidant protection, and neurotransmitter recycling through the glutamate-glutamine axis. Within this cohesive framework, the regulation of pH mediated by carnosine and the metabolic pathways reliant on glutamine collectively enhance mitochondrial functionality, neuroplasticity, and the mitigation of neuroinflammation. Physical exercise further intensifies these interactions by influencing both the availability of carnosine and the dynamics of glutamine, thereby strengthening their significance in the communication between muscle and brain. This review consolidates the prevailing evidence regarding BA and glutamine within a unified mechanistic paradigm, emphasizing their synergistic contributions to the regulation of metabolic resilience and neuroprotection in the context of aging and neurodegenerative disorders. In aggregate, this integrative viewpoint offers a more robust biological justification for the targeted modulation of these amino acids as complementary agents within the muscle-brain axis. Future investigations should prioritize personalized interventions that integrate amino acid supplementation and exercise regimens within the paradigm of predictive, preventive, and personalized medicine to enhance the trajectories of healthy aging.
Indexed as
Identifiers
42322395What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.